Consulting & Advisory
FarGrit works with Biotech, Pharma, MedTech, and Healthcare organisations at the intersection of product innovation, AI acceleration, and commercial development. Our work spans early-stage preclinical ventures through to commercial launch and loss-of-exclusivity strategy at global scale.
We bring a rare combination: McKinsey-trained strategic rigour, hands-on product and design leadership, and active operator experience building companies in the sectors we advise.
What We Do
AI-Accelerated R&D and Product Development
We help organisations apply AI and human-centred design to compress development timelines and improve decision quality. This includes target identification and candidate selection, clinical trial design and patient engagement, digital companion product development, and the architecture of AI-assisted workflows for regulated environments. We have built and run multi-model AI evaluation systems in production clinical contexts — we don’t advise on this from the outside.
Go-to-Market and Launch Acceleration
We support Pharma and Biotech organisations bringing new medicines and diagnostics to market. This covers commercial strategy, Target Product Profile development, HCP and patient engagement design, omnichannel capability building, and brand differentiation. We have led GTM work for top-tier oncology brands and blockbuster drugs facing biosimilar entry.
Loss of Exclusivity Strategy
Defending against biosimilar entry requires more than price strategy. We develop differentiated customer experience and beyond-the-pill propositions — drug delivery systems, digital companion apps, connected care ecosystems — that create durable value when the core molecule is no longer protected.
Business Development and Partnering
We support deal-making with Big Pharma, Biotech, and strategic investors. This includes due diligence on R&D assets, drug candidates, and medical technology; capability and readiness assessments; and negotiating Master Services Agreements, performance-based contracts, and joint venture structures. We deploy a broad life sciences network across Australia, the US, and Europe.
Device and Digital Product Development
We lead the design and development of medical devices, drug delivery systems, drug-digital combination products, and Software as a Medical Device (SaMD). Our approach integrates human factors design, regulatory awareness, and agile development — from concept through to validated product.
Organisational Capability Building
We build CX, design, and agile marketing capabilities inside life sciences organisations. This includes team design, hiring, process development, and embedding new ways of working in commercial and R&D functions.
Where We Work
FarGrit has deep experience across Oncology, Immunology, Cardiology, Respiratory, Diabetes, Neurology, Rare Diseases, and Advanced Surgery. We work with organisations at every stage — from preclinical ventures through to global commercial operations.
Past and current clients include organisations across Pharma, Biotech, MedTech, and Healthcare delivery. Client work from the Veryday and McKinsey years includes Merck, Janssen, Roche, Lilly, Sanofi, AstraZeneca, Pfizer, GSK, Galderma, and Getinge, among others.
Engagements
We take on a small number of focused advisory and consulting engagements at any time. Engagements are structured around a defined problem and outcome — not open-ended retainers.
If you are working on something at the edge of life sciences, AI, and product — and you want a thinking partner who has built in that space — reach out.